Brd4 siRNA (Hs_BRD4_6 FlexiTube, SI03190845; Qiagen) or control siRNA (AllStars negative control, 1027281; Qiagen) was transfected into 20861 cells using RNAimax, following the manufacturer’s instruction. The following antibodies were used: ant-γ-H2AX (phospho-histone H2AX [Ser139], 05-636 [Millipore]), anti-Rad51 (ab213 [Abcam]), anti-MED1 (A300-793A [Bethyl Laboratories]), anti-H3K27ac (07-360 [Millipore]), anti-CDK9 (sc-8338 [Santa Cruz]), and anti-Brd4 (A301-985A; 1.2 µg per IP [Bethyl Laboratories]). Affinity-purified Brd4 C-terminus-specific anti-Brd4 antiserum (MCB2) has been described previously (12 (link)). Brd4 (8H2 mouse monoclonal antibody) binds the BDII region and is from Cheng-Ming Chiang (UT Southwestern) (46 (link)). For immunofluorescence, antibodies were diluted 1:100. For ChIP, 3.0 µg antibody was used per IP unless stated otherwise.
Free full text: Click here